Skip to content

Phreesia

US · PHR #3570 by market cap Listed 2019
10.50 +0.25 +2.44%
Live - 5344 symbols - heartbeat 550s ago · 2026-10-08 04:23
Pre-market 10.70 +1.90%
After-hours 10.50 0.00%
Market cap
651.74M
P/B
1.75
EPS
0.04
Reader sentiment Are you bullish or bearish on PHR?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Ownership Signal how this is computed

Distributing
  • Total institutional ownership fell 0.3 percentage points.

Institutional ownership

Held by institutions
98.68% -0.30pp
Institutions
277
As of
2026/Q3 vs. prior period

Ownership vs. money flow

Aligned

Institutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Holder types

Mutual Fund59.80%
Hedge Fund15.42%
VC/PE Fund14.38%
Individual/Insider6.29%
Private Company3.94%
Public Company3.13%
Insurance Company1.12%
Government Pension Fund0.68%
Family Office/Trust0.15%

Top holders as of 2026-06-30

Pale Fire Capital SE 14.38% · 8.92M sh
BlackRock 11.31% · 7.02M sh
AQR Capital Management 4.95% · 3.07M sh
Vanguard Portfolio Management, LLC 4.81% · 2.99M sh
Vanguard Capital Management, LLC 4.76% · 2.95M sh
Acadian Asset Management LLC 2.59% · 1.60M sh
State Street Global Advisors 2.54% · 1.58M sh
T. Rowe Price Group, Inc. 2.26% · 1.41M sh
Chaim Indig 2.21% · 1.37M sh
Geode Capital Management, LLC 2.11% · 1.31M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 31 buys · 19 sells

NameRoleStake
Pale Fire Capital SE -- 14.38%
Chaim Indig Chief Executive Officer 2.21%
Evan Roberts Co-Founder & COO 1.67%
David Linetsky Senior Vice President of Life Sciences 0.71%
Balaji Gandhi Chief Financial Officer 0.56%
Amy VanDuyn Officer 0.42%
Michael Weintraub Independent Chairperson 0.30%
Edward Cahill Independent Director 0.11%
Yvonne Hui VP & Principal Accounting Officer 0.10%
Allison Hoffman General Counsel 0.08%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-09-20 Allison Hoffman General Counsel Automatic Disposition -6,662 $10.08
2026-09-17 Allison Hoffman General Counsel Sale to Issuer -7,401 $10.42
2026-09-17 Evan Roberts Co-Founder & COO Sale to Issuer -4,476 $10.42
2026-09-17 Amy VanDuyn Officer Sale to Issuer -2,876 $10.42
2026-09-17 David Linetsky Senior Vice President of Life Sciences Sale to Issuer -4,794 $10.42
2026-09-13 Allison Hoffman General Counsel Other Acquisition +14,063 --
2026-09-13 Evan Roberts Co-Founder & COO Other Acquisition +8,113 --
2026-09-13 Amy VanDuyn Officer Other Acquisition +6,490 --
2026-09-13 David Linetsky Senior Vice President of Life Sciences Other Acquisition +8,816 --
2026-08-31 Allison Hoffman General Counsel Other Acquisition +108,000 --
2026-08-31 Allison Hoffman General Counsel Other Derivative Acquisition +85,000 --
2026-08-31 Balaji Gandhi Chief Financial Officer Other Acquisition +192,000 --
2026-08-31 Balaji Gandhi Chief Financial Officer Other Derivative Acquisition +155,000 --
2026-08-31 Chaim Indig Chief Executive Officer Other Acquisition +500,000 --
2026-08-31 Chaim Indig Chief Executive Officer Other Derivative Acquisition +400,000 --
2026-08-31 Evan Roberts Co-Founder & COO Other Acquisition +192,000 --
2026-08-31 Evan Roberts Co-Founder & COO Other Derivative Acquisition +155,000 --
2026-08-31 Amy VanDuyn Officer Other Acquisition +88,000 --
2026-08-31 Amy VanDuyn Officer Other Derivative Acquisition +67,500 --
2026-08-31 David Linetsky Senior Vice President of Life Sciences Other Acquisition +202,000 --

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-10-08 04:23:07 · For reference only, not investment advice and not tailored to your situation.